Microbot Medical Inc (MBOT)

Etorro trading 970x250
Microbot Medical Inc (MBOT) Logo

About Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body’s vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Address: 25 Recreation Park Drive, Hingham, MA, United States, 02043

Microbot Medical Inc News and around…

Latest news about Microbot Medical Inc (MBOT) common stock and company :

Microbot Medical Secures Additional Patent for the LIBERTY® Robotic System in the United States
19 Nov, 2021 Yahoo! Finance

HINGHAM, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance for a second patent application covering the Company’s LIBERTY® Robotic System. Globally, the Company now has 46 patents issued/allowed and 24 pending patent applications and is continuously submitting applications to protect its Intellectual Property. “We believe that the U.S. is the largest and most significant

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
06 Oct, 2021 FinancialContent

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market ...

Microbot Medical Secures Patent for LIBERTY® Robotic System in the United States
06 Oct, 2021 Yahoo! Finance

HINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance covering the Company’s LIBERTY® Robotic System. Globally, the Company now has 45 patents issued/allowed and 24 pending patent applications. “This achievement is yet another meaningful milestone that adds a secure foundation to build our sustainable competitive advantage. This IP allows us to protect our assets gl

58 Biggest Movers From Friday
23 Aug, 2021 FinancialContent

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell ...

Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board
05 Aug, 2021 FinancialContent

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to the A3 adenosine receptor (A3AR), addressing cancer, liver and inflammatory diseases, announced today that Yossi Borenstein, Shizim group CEO, was elected as an External Director at the Company’s recent annual general meeting.

Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology
29 Jun, 2021 FinancialContent
Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology
29 Jun, 2021 Yahoo! Finance

HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company’s innovative ‘One & Done’ guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued/allowed and 24 pending patent applications. “This latest patent allowance will expand protecti

Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
26 Jun, 2021 Yahoo! Finance

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Leading Interventional Cardiologist Dr. Giora Weisz Joins Microbot Medical’s Scientific Advisory Board
07 Jun, 2021 FinancialContent
Microbot Medical Secures Additional Protection for the One & Done Guidewire Technology with another Notice of Patent Allowance
04 Jun, 2021 FinancialContent
Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology
04 Feb, 2021 FinancialContent
Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt
27 Jan, 2021 FinancialContent

FDA Feedback Reflects Strength of Pre-Clinical Safety Data; Maintains Q3 2022 Projected Commencement of First-in-Human Clinical Trial

Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists
21 Jan, 2021 FinancialContent

Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders

Microbot Medical Announces Positive Results of Additional Animal Feasibility Study with LIBERTYTM Robotic System
14 Jan, 2021 FinancialContent
Microbot Medical Demonstrates Significant Progress in 2020; Outlines Anticipated Milestones for 2021
11 Jan, 2021 FinancialContent
Microbot Medical to Share Current Progress and Expected 2021 Milestones at Upcoming Conferences
07 Jan, 2021 FinancialContent
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
28 Dec, 2020 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Microbot Medical Secures Patents in Multiple Global Jurisdictions
17 Nov, 2020 FinancialContent
Microbot Medical to Highlight Progress and Recent Achievements at H.C. Wainwright 6th Annual Israel Conference
09 Nov, 2020 FinancialContent

Microbot Medical Inc (MBOT) is a NASDAQ Common Stock listed in , ,

970x250